Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

RATIONALE: Schizophrenia remains among the most prevalent neuropsychiatric disorders, and current treatment options are accompanied by unwanted side effects. New treatments that better address core features of the disease with minimal side effects are needed. OBJECTIVES: As a new therapeutic approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Gretchen L., Vanover, Kimberly E., Zhu, Hongwen, Miller, Diane B., O’Callaghan, James P., Tomesch, John, Li, Peng, Zhang, Qiang, Krishnan, Vaishnav, Hendrick, Joseph P., Nestler, Eric J., Davis, Robert E., Wennogle, Lawrence P., Mates, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302236/
https://www.ncbi.nlm.nih.gov/pubmed/25120104
http://dx.doi.org/10.1007/s00213-014-3704-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302236/
https://www.ncbi.nlm.nih.gov/pubmed/25120104
http://dx.doi.org/10.1007/s00213-014-3704-1

Ejemplares similares